Heritability of tear fluid cytokines in healthy twins

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Purpose
Ocular surface disease is common and it is associated with elevated concentration levels of cytokines in tear fluid. Studies of the normal variation in tear fluid inflammatory markers are lacking. New knowledge may help guide research into ocular surface disease biomarkers and therapeutics.

Methods
In this prospective twin cohort study, healthy individuals were recruited from a population-based registry. Tear fluid was collected with the Schirmer test strips was submerged in phosphate buffered saline and stored at −80° before undergoing 27-cytokine multiplex immunoassay analysis. Broad-sense heritability (h2) of cytokine concentrations was analyzed.

Results
90 participants (23 monozygotic and 22 dizygotic twin pairs) were included. Data availability allowed for heritability analysis of 15 cytokines, and a h2 >50% was seen for 10 cytokines. A statistical power of >80% was achieved for heritability analyses of the cytokines interferon gamma induced protein 10 (h2 = 94.8%), eotaxin (89.8%), interleukin 7 (86.6%), interleukin 1β (82.2%) and monocyte chemoattractant protein 1 (68.2%).

Conclusions
The tear fluid concentration of several analyzed cytokines was found to be highly heritable. A considerable amount of the inter-individual variation observed for the concentration of certain tear fluid cytokines can be linked to hereditary factors that cannot easily be modified by changing factors in the environment of patients. This suggests that a higher success in ocular surface disease drug discovery may be anticipated for drugs that have targets in specific populations, and points to the importance of emphasizing known preventive measures of ocular surface disease and examinations of close relatives of patients with ocular surface disease, such as dry eye disease.
OriginalsprogEngelsk
TidsskriftOcular Surface
Vol/bind32
Sider (fra-til)145-153
Antal sider9
ISSN1542-0124
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
This work was supported by THE VELUX FOUNDATIONS (Author JB, grant no. 00028975 , https://veluxfoundations.dk/en ), Rigshospitalets Forskningsudvalg (Author MB, grant no. E−23334-02 , https://www.rigshospitalet.dk/forskning/om-forskningen/Sider/forskningsudvalget.aspx ), P. Carl Petersens Fond (MB, grant no. 19102 , https://www.pcarlp-fond.dk/ ), Helsefonden (MB, grant no. 19-B-0063 , https://helsefonden.dk/ ), Aase og Ejnar Danielsens Fond (MB, grant no. 18-10-0698 , https://danielsensfond.dk/ ), Beckett Fonden (MB, grant no. 19-2-3490 , https://beckett-fonden.dk/ ) and Einar Willumsens Mindelegat (MB, grant no. 500028 , https://www.legatbogen.dk/fabrikant-einar-willumsens-mindelegat/stoetteomraade/7684 ). The study was supported by the European Union under H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) (project ID 780989 MERLIN ) ( https://cordis.europa.eu/project/rcn/213189_en.html ) and Department of Medical Biochemistry, Oslo University Hospital .

Publisher Copyright:
© 2024 Elsevier Inc.

ID: 385586481